With the increased global demand for Chinese herbal medicines (CHM), the standardization and internationalization of CHM have been of interest to the scientific and research communities. However, there are some challenges in ensuring the quality of research and the acceptability globally since the complexity of the ingredients in CHM and their extracts. In this review, the international best practices in research reporting guidelines of CHM were summarized and discussed, including approaches to sourcing, cultivation and harvesting, extraction, preparation, bioactive constituents and quality control markers, as well as pesticide residues and safety, in vitro and in vivo studies, clinical trials, and the application of artificial intelligence. This review aims to enhance the reproducibility, and ensure precise interpretation of results, and hence, to improve research quality and transparent reporting, to facilitate the internationalization and standardization of CHM.

Chinese herbal medicines  /  standardization  /  internationalization  /  best practice in reporting  /  guidelines